Dr. Ana Maria Lopez, MD, MPH, MACP

Media Releases

Get to know Medical Oncologist Dr. Ana Maria Lopez, who serves patients in Philadelphia, Pennsylvania.

Dr. Lopez is Professor and Vice Chair of Medical Oncology & Chief of Cancer Services at Sidney Kimmel Cancer Center – Jefferson Health in Philadelphia, Pennsylvania. She brings her expertise in breast and gynecologic cancers, integrative medicine, telehealth, and cancer disparities with her to her work at the Sidney Kimmel Cancer Center of Thomas Jefferson University.

Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A medical professional who practices oncology is an oncologist. An oncologist is a doctor who treats cancer and provides medical care for a person diagnosed with cancer. They lead a cancer treatment team of various healthcare professionals, treat patients with medical approaches to care, coordinate treatment plans and prescribe various types of treatment, including chemotherapy and immunotherapy, as well as assist patients with pain management.

The Sidney Kimmel Cancer Center is committed to person-focused, multidisciplinary cancer care where nationally renowned cancer experts provide care for patients with all types of cancers, including cancers of the lung, colon and rectum, breast, pancreas, stomach, esophagus, prostate, bladder and head and neck, as well as melanoma, leukemia, lymphoma and multiple and uveal myeloma. The Center also performs autologous and allogeneic bone marrow transplantation for selected forms of cancer.

Dr. Lopez sees herself as an ameliorist, one who seeks to make things better. Her career trajectory demonstrates this commitment to care and to making better care accessible to more people. Following undergraduate studies in Philosophy at Bryn Mawr College, she earned her medical degree from Sidney Kimmel Medical College of Thomas Jefferson University. She then trained in internal medicine and hematology-oncology, completed a Master of Public Health degree in Health Policy and Administration, and was awarded a Cancer Prevention and Etiology Fellowship (T32, NCI) at the University of Arizona and the Arizona Cancer Center.

Subsequently, she joined the faculty of the University of Arizona College of Medicine and earned tenure and the academic rank of professor. She also served as medical director of the Women’s Health Initiative, founding medical director of the Arizona Telemedicine Program, and associate dean of outreach and multicultural affairs.

In 2015, Dr. Lopez moved to University of Utah Health Sciences, where she served as a professor of medicine at the University of Utah School of Medicine, director of cancer health equity at the Huntsman Cancer Institute, and associate vice president for health equity and inclusion at University of Utah Health Sciences. 

Dr. Lopez was recruited to the Sidney Kimmel Cancer Center in 2018 where she joined the faculty of the Sidney Kimmel Medical College and is affiliated with Thomas Jefferson University Hospital, Jefferson Health New Jersey, and Jefferson Methodist Hospital.

With a commitment to excellence, Dr. Lopez is board-certified in medical oncology and hematology/oncology by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Among her professional affiliations, Dr. Lopez is President Emeritus and Master of the American College of Physicians; member of the Education Committee and of the Telemedicine Standards Committee of the American Society of Clinical Oncology; and member of the Steering Committee, Group on Women In Medicine and Science, Association of American Medical Colleges. Dr. Lopez formerly served on the Board of the National Hispanic Medical Association, and is past-Chair of the Cancer Health Disparities Committee of the American Society of Clinical Oncology.

Recognized for her expertise in cancer prevention and telemedicine, Dr. Lopez has approximately 100 peer-reviewed journal articles and multiple book chapters. She has dedicated her career to addressing health inequities through community-based participatory research and through clinical trials that assess telecommunications technology to facilitate access to clinical care and education. She served as a member of Patient-Centered Outcomes Research Institute (PCORI) Advisory Panel, Healthcare Delivery and Disparities Research from August 2016 to August 2019.

Recommended Articles

• Is Ovarian Cancer Genetic?

  What is Ovarian Cancer?Ovarian cancer is a very dangerous disease that occurs when malignant cells are found in the ovaries. It effects mostly women from 60-63 years old, but can happen to a woman of any age. Ovaries are a pair of organs that produce fertile hormones and eggs in women. Because...

• Is it Lung Cancer or COPD?

  Chronic Obstructive Pulmonary Disease (COPD) and lung cancer are two ends of the same spectrum. Though vastly different in core characteristics, they share many symptoms such as painful wheezing, a persistent cough, and the production of copious mucus. Both these diseases have similar causes and...

• Jackie Kennedy Onassis's Battle with Lymphoma

  Jackie Kennedy Onassis is one of the most iconic first ladies of all time, and an important cultural icon of the 20th century. Not only did she establish a model for the behavior and protocol of the first ladies that would follow her, but she was also a fashion icon and a well-respected book editor...

• Does One Factor Double Death Risk from Breast Cancer?

  Researchers from Sweden look to identify whether certain risk factors present an increased long-term risk of death from breast cancer. Read on to learn more.The risk of developing breast cancer increases with age, as it tends to develop in women between the ages of 50-69. However, there are also...

• Tall Women Have Higher Risk of Cancer

  According to a new study published online in the Lancet Oncology, taller women may have a greater risk for a variety of cancers, when compared to shorter women. Many earlier studies also have shown the link between height and increased risk of cancer; the reason for this link is still unclear....

• Is a Mastectomy an Efficient Option to Treat Breast Cancer?

  A mastectomy refers to the surgery performed to remove the breasts, either completely or partially. This was one of the traditional methods in the treatment of breast cancer for a long time. It is also used as a method to reduce the chances of developing breast cancer for women who have a high risk...